Winfried Kern to Blood Component Transfusion
This is a "connection" page, showing publications Winfried Kern has written about Blood Component Transfusion.
Connection Strength
0.038
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.038